RVU Ryvu Therapeutics S.A.

GPW · PL · Healthcare · Biotechnology · ryvu.com
4.196USD16.88 PLN · GPW-0.12%Mkt Cap: 97.02M USDP/E: —

Ryvu Therapeutics S.A., a clinical-stage drug discovery and development company, engages in developing of small molecule therapies for treatment in oncology in Poland, European Union, and internationally. The company's l…